Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

alpha1-Adrenoceptor antagonist effective in suppressing prostate cancer growth

Sep. 6, 1996

Kosan receives funds for drug design

Sep. 6, 1996

Generic product from Barr Laboratories cleared by FDA

Sep. 6, 1996

Abbott evaluating clitocine analogues

Sep. 6, 1996

BRCA1 licensing agreement

Aug. 30, 1996

Minoxidil effective and safe for chemotherapy-induced hair loss in women

Aug. 30, 1996

Gene involved in colon cancer development revealed

Aug. 30, 1996

DNA cleaving reagents from the University of Cincinnati

Aug. 30, 1996

Cancer genetics joint venture

Aug. 30, 1996

Inflazyme/SuperGen future licensing agreement

Aug. 30, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...